| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.75e-05 | 104 | 156 | 7 | GO:0016407 | |
| GeneOntologyMolecularFunction | PLC activating G protein-coupled glutamate receptor activity | 6.06e-05 | 2 | 156 | 2 | GO:0001639 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.13e-04 | 187 | 156 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 3.60e-04 | 4 | 156 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.64e-04 | 78 | 156 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | acyltransferase activity | SPTLC3 RAD18 RNF152 TRIM58 NAT9 ACAT2 JADE1 TGM6 FBXL3 FASN KLHL13 TAF1 UBE2QL1 TAF1L KAT14 EPB42 | 3.82e-04 | 775 | 156 | 16 | GO:0016746 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | PRAMEF10 PSMA6 NSD1 NIF3L1 TACC2 PPARD GRM1 CTBP2 TAF1 TAF1L DNMT1 | 4.48e-04 | 417 | 156 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 5.78e-04 | 238 | 156 | 8 | GO:0016747 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 5.84e-04 | 363 | 156 | 10 | GO:0106310 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 5.97e-04 | 5 | 156 | 2 | GO:0099530 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 5.97e-04 | 5 | 156 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.73e-04 | 51 | 156 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK36 MAK RIPK3 CDK15 MARK1 MAPKAPK2 CILK1 MAP3K6 TNK2 TAF1 TAF1L | 7.81e-04 | 446 | 156 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 8.97e-04 | 55 | 156 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | kinase activity | STK36 MAK RIPK3 CDK15 MARK1 MAPKAPK2 CILK1 MAGI3 MAP3K6 LRGUK CSK PIK3CD TNK2 TAF1 TAF1L | 9.74e-04 | 764 | 156 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.24e-03 | 102 | 156 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.24e-03 | 60 | 156 | 4 | GO:0034212 | |
| Domain | TFIID_sub1_DUF3591 | 6.84e-05 | 2 | 155 | 2 | IPR022591 | |
| Domain | GluR_Homer-bdg | 6.84e-05 | 2 | 155 | 2 | PF10606 | |
| Domain | TBP-binding | 6.84e-05 | 2 | 155 | 2 | PF09247 | |
| Domain | Metabotropic_Glu_rcpt_Homer-bd | 6.84e-05 | 2 | 155 | 2 | IPR019588 | |
| Domain | DUF3591 | 6.84e-05 | 2 | 155 | 2 | PF12157 | |
| Domain | GPCR_3_mtglu_rcpt_1 | 6.84e-05 | 2 | 155 | 2 | IPR001256 | |
| Domain | Presenilin | 6.84e-05 | 2 | 155 | 2 | PF01080 | |
| Domain | GluR_Homer-bdg | 6.84e-05 | 2 | 155 | 2 | SM01229 | |
| Domain | TAF_II_230-bd | 6.84e-05 | 2 | 155 | 2 | IPR009067 | |
| Domain | Peptidase_A22A | 6.84e-05 | 2 | 155 | 2 | IPR001108 | |
| Domain | GPCR_3_mtglu_rcpt_5 | 6.84e-05 | 2 | 155 | 2 | IPR000202 | |
| Domain | - | 6.84e-05 | 2 | 155 | 2 | 1.10.1100.10 | |
| Domain | TAF1_animal | 6.84e-05 | 2 | 155 | 2 | IPR011177 | |
| Domain | Ndr | 4.06e-04 | 4 | 155 | 2 | PF03096 | |
| Domain | NDRG | 4.06e-04 | 4 | 155 | 2 | IPR004142 | |
| Pubmed | RAD18 RAPGEF6 PRAMEF10 PSAP MARK1 NSD1 RICTOR TFIP11 TACC2 FRYL JADE1 ANKRD50 PIK3CD GLI1 VPS35L NFRKB OGDHL NLRP4 VPS13B | 6.65e-07 | 1084 | 160 | 19 | 11544199 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 SPTLC3 MCM8 CACNA2D2 MAPKAPK2 CILK1 MAGI3 NFASC FRYL PPM1K SFMBT2 HPS3 ARFGEF3 CMIP NDRG1 VPS35L ASPH TNK2 CTBP2 LIMCH1 LTBR VPS13B | 1.43e-06 | 1489 | 160 | 22 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAD18 RAPGEF6 RICTOR TFIP11 MECP2 FASN NDRG1 CHTF18 ASPH EIF4G1 NFRKB USP7 LIMCH1 DNMT1 HDLBP | 3.22e-06 | 774 | 160 | 15 | 15302935 |
| Pubmed | 8.54e-06 | 103 | 160 | 6 | 10574462 | ||
| Pubmed | Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca2+ cross-talk. | 2.10e-05 | 2 | 160 | 2 | 21285369 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33973882 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15526354 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22028929 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9185557 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12460542 | ||
| Pubmed | MAGI-1: a widely expressed, alternatively spliced tight junction protein. | 2.10e-05 | 2 | 160 | 2 | 11969287 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34067945 | ||
| Pubmed | Presenilins regulate synaptic plasticity in the perforant pathways of the hippocampus. | 2.10e-05 | 2 | 160 | 2 | 36710361 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27881780 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27177724 | ||
| Pubmed | Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. | 2.10e-05 | 2 | 160 | 2 | 11715026 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34102969 | ||
| Pubmed | Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction. | 2.10e-05 | 2 | 160 | 2 | 26349604 | |
| Pubmed | Dysregulation of hypoxia-inducible factor by presenilin/γ-secretase loss-of-function mutations. | 2.10e-05 | 2 | 160 | 2 | 23365231 | |
| Pubmed | Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE. | 2.10e-05 | 2 | 160 | 2 | 17401156 | |
| Pubmed | Identification of Structural Calcium Binding Sites in Membrane-Bound Presenilin 1 and 2. | 2.10e-05 | 2 | 160 | 2 | 32420742 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33413468 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31167792 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18367332 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29078389 | ||
| Pubmed | Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. | 2.10e-05 | 2 | 160 | 2 | 19834068 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18971484 | ||
| Pubmed | Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications. | 2.10e-05 | 2 | 160 | 2 | 38227890 | |
| Pubmed | Epigenetic regulation of presenilin 1 and 2 in the cerebral cortex of mice during development. | 2.10e-05 | 2 | 160 | 2 | 25652771 | |
| Pubmed | Loss of presenilin function enhances tau phosphorylation and aggregation in mice. | 2.10e-05 | 2 | 160 | 2 | 34593029 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22681774 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25204494 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19584449 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28619096 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 8574969 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12846562 | ||
| Pubmed | FK506 binding protein 10: a key actor of collagen crosslinking in clear cell renal cell carcinoma. | 2.10e-05 | 2 | 160 | 2 | 34388114 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23280324 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28378777 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38804708 | ||
| Pubmed | Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition. | 2.10e-05 | 2 | 160 | 2 | 17093122 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37864790 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24699228 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22842574 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15287885 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15537629 | ||
| Pubmed | MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5. | 2.10e-05 | 2 | 160 | 2 | 22973007 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12885769 | ||
| Pubmed | Age and sex dependent alteration in presenilin expression in mouse cerebral cortex. | 2.10e-05 | 2 | 160 | 2 | 17874292 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27571988 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34403156 | ||
| Pubmed | Two homologous genes causing early-onset familial Alzheimer's disease. | 2.10e-05 | 2 | 160 | 2 | 9246482 | |
| Pubmed | A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein. | 2.10e-05 | 2 | 160 | 2 | 16103124 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18297084 | ||
| Pubmed | Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. | 2.10e-05 | 2 | 160 | 2 | 15128703 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31102766 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 21914807 | ||
| Pubmed | Environment enrichment rescues the neurodegenerative phenotypes in presenilins-deficient mice. | 2.10e-05 | 2 | 160 | 2 | 17614943 | |
| Pubmed | Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction. | 2.10e-05 | 2 | 160 | 2 | 20854432 | |
| Pubmed | PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach. | 2.10e-05 | 2 | 160 | 2 | 24927704 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20953898 | ||
| Pubmed | Phenylpiperidine-type γ-secretase modulators target the transmembrane domain 1 of presenilin 1. | 2.10e-05 | 2 | 160 | 2 | 22002539 | |
| Pubmed | Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions. | 2.10e-05 | 2 | 160 | 2 | 34500587 | |
| Pubmed | Presence of presenilin 1/2 affects the invasion and replication of Salmonella typhimurium. | 2.10e-05 | 2 | 160 | 2 | 15922300 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18539391 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9521418 | ||
| Pubmed | Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. | 2.10e-05 | 2 | 160 | 2 | 9450754 | |
| Pubmed | The mechanism of γ-Secretase dysfunction in familial Alzheimer disease. | 2.10e-05 | 2 | 160 | 2 | 22505025 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 9298903 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36805914 | ||
| Pubmed | Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. | 2.10e-05 | 2 | 160 | 2 | 12559117 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22496554 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18554818 | ||
| Pubmed | Novel role of presenilins in maturation and transport of integrin beta 1. | 2.10e-05 | 2 | 160 | 2 | 18293935 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16135086 | ||
| Pubmed | Presenilin 1 and 2 are expressed differentially in the cerebral cortex of mice during development. | 2.10e-05 | 2 | 160 | 2 | 22796216 | |
| Pubmed | Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation. | 2.10e-05 | 2 | 160 | 2 | 25960197 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27392515 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34662541 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 10518543 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29867447 | ||
| Pubmed | MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice. | 2.10e-05 | 2 | 160 | 2 | 28879407 | |
| Pubmed | Late onset familial Alzheimer's disease: novel presenilin 2 mutation and PS1 E318G polymorphism. | 2.10e-05 | 2 | 160 | 2 | 18350357 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16620965 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36944398 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24018889 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28982591 | ||
| Pubmed | Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks. | 2.10e-05 | 2 | 160 | 2 | 32992716 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 7651536 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 37465679 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31376499 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 36370840 | ||
| Pubmed | USP7 is essential for maintaining Rad18 stability and DNA damage tolerance. | 2.10e-05 | 2 | 160 | 2 | 25961918 | |
| Pubmed | Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. | 2.10e-05 | 2 | 160 | 2 | 22503161 | |
| Pubmed | Age-related neuropsychiatric symptoms in presenilins conditional double knockout mice. | 2.10e-05 | 2 | 160 | 2 | 23792007 | |
| Pubmed | Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. | 2.10e-05 | 2 | 160 | 2 | 12684521 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11987239 | ||
| Pubmed | Adult neurogenesis is functionally associated with AD-like neurodegeneration. | 2.10e-05 | 2 | 160 | 2 | 17980611 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16014629 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18035501 | ||
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | RAD18 PSEN1 MARK1 INPP1 SLC22A15 RICTOR TACC2 FHIP2A SFMBT2 ARFGEF3 WDR20 ASPH DPY19L4 LIMCH1 TMCO3 RHOF VPS13B MPPED1 HDLBP | 2.96e-09 | 583 | 159 | 19 | M17454 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ACSL6 RAPGEF6 THSD7A TRIM58 MARK1 RAB22A SLC22A15 MAGI3 NFASC RICTOR GRM1 GRM5 ARFGEF3 CMIP ZFHX4 NALCN PIK3CD KLHL13 OGDHL TNK2 TMCO3 UBE2QL1 CNTN1 | 2.50e-07 | 1106 | 159 | 23 | M39071 |
| Coexpression | GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP | 1.26e-05 | 176 | 159 | 8 | M7725 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ACSL6 TRIM58 MARK1 ATP8A2 TNFRSF6B NFASC GRM5 ARFGEF3 CMIP ZFHX4 NALCN PIK3CD OGDHL TNK2 UBE2QL1 | 2.64e-05 | 703 | 159 | 15 | M39070 |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-08 | 199 | 160 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.98e-07 | 180 | 160 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.15e-07 | 188 | 160 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.68e-07 | 191 | 160 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-07 | 192 | 160 | 8 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-07 | 192 | 160 | 8 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 4.87e-07 | 192 | 160 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-07 | 192 | 160 | 8 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.70e-07 | 196 | 160 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 6.15e-07 | 198 | 160 | 8 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.15e-07 | 198 | 160 | 8 | 8a1f984e46f4fa5be33027b9dbaa2ca060a2245d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.15e-07 | 198 | 160 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.39e-07 | 199 | 160 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-06 | 154 | 160 | 7 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 165 | 160 | 7 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.58e-06 | 168 | 160 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.78e-06 | 178 | 160 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.07e-06 | 180 | 160 | 7 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.22e-06 | 181 | 160 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.37e-06 | 182 | 160 | 7 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.37e-06 | 182 | 160 | 7 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.37e-06 | 182 | 160 | 7 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.53e-06 | 183 | 160 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.70e-06 | 184 | 160 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 184 | 160 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 4.87e-06 | 185 | 160 | 7 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.04e-06 | 186 | 160 | 7 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.04e-06 | 186 | 160 | 7 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.41e-06 | 188 | 160 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 5.80e-06 | 190 | 160 | 7 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.80e-06 | 190 | 160 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.80e-06 | 190 | 160 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-06 | 190 | 160 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 5.80e-06 | 190 | 160 | 7 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 6.00e-06 | 191 | 160 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.00e-06 | 191 | 160 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.00e-06 | 191 | 160 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.00e-06 | 191 | 160 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 6.21e-06 | 192 | 160 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 192 | 160 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.21e-06 | 192 | 160 | 7 | 5795ad6605565ce194341d08c65aae4b526dac84 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.21e-06 | 192 | 160 | 7 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-06 | 193 | 160 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 193 | 160 | 7 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.43e-06 | 193 | 160 | 7 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-06 | 193 | 160 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 193 | 160 | 7 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.65e-06 | 194 | 160 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 194 | 160 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.65e-06 | 194 | 160 | 7 | 46266d3d9af7000dc1381b1c8e55047193cbcf94 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.87e-06 | 195 | 160 | 7 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.87e-06 | 195 | 160 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 196 | 160 | 7 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 1bfc3c85ce9501f52a912e53cbded7de74572b9d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 196 | 160 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | Goblet_cell|World / shred on cell type and cluster | 7.35e-06 | 197 | 160 | 7 | d82d3204f24c95771c1496c28e3fbc6e2442199b | |
| ToppCell | C_04|World / shred on cell type and cluster | 7.35e-06 | 197 | 160 | 7 | 885604356e19a850b0e601c3167ad26b8180bcec | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.35e-06 | 197 | 160 | 7 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 198 | 160 | 7 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.59e-06 | 198 | 160 | 7 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 198 | 160 | 7 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.85e-06 | 199 | 160 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial-oRG/Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.85e-06 | 199 | 160 | 7 | 0b96fad1be02f0fe7a608207770cc56a6b6b291e | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.85e-06 | 199 | 160 | 7 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.85e-06 | 199 | 160 | 7 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.85e-06 | 199 | 160 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.85e-06 | 199 | 160 | 7 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.11e-06 | 200 | 160 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.11e-06 | 200 | 160 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.11e-06 | 200 | 160 | 7 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.11e-06 | 200 | 160 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 164 | 160 | 6 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 166 | 160 | 6 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-05 | 169 | 160 | 6 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-05 | 169 | 160 | 6 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.38e-05 | 169 | 160 | 6 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-05 | 169 | 160 | 6 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-ILC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.98e-05 | 174 | 160 | 6 | 7c50bf9da37711266cc077eef4e54b58463f1d37 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.10e-05 | 175 | 160 | 6 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 175 | 160 | 6 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-05 | 176 | 160 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-05 | 176 | 160 | 6 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-05 | 176 | 160 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-05 | 177 | 160 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.51e-05 | 178 | 160 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 179 | 160 | 6 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.80e-05 | 180 | 160 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.11e-05 | 182 | 160 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.11e-05 | 182 | 160 | 6 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-05 | 183 | 160 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-05 | 183 | 160 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-05 | 185 | 160 | 6 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.93e-05 | 187 | 160 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| Disease | Alzheimer's disease 3 (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0110042 (implicated_via_orthology) | |
| Disease | Bruck syndrome | 2.71e-05 | 2 | 154 | 2 | C0432253 | |
| Disease | response to docetaxel trihydrate | 2.71e-05 | 2 | 154 | 2 | GO_1902519 | |
| Disease | Bruck syndrome 2 | 2.71e-05 | 2 | 154 | 2 | C1836602 | |
| Disease | Bruck syndrome 1 | 2.71e-05 | 2 | 154 | 2 | C1850168 | |
| Disease | arecaidine measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0801112 | |
| Disease | Endometrioid carcinoma ovary | 2.68e-04 | 5 | 154 | 2 | C0346163 | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Asphyxia Neonatorum | 4.00e-04 | 6 | 154 | 2 | C0004045 | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 5.59e-04 | 7 | 154 | 2 | cv:CN043596 | |
| Disease | clopidogrel metabolite measurement | 6.78e-04 | 33 | 154 | 3 | EFO_0007966 | |
| Disease | sleep measurement | 7.29e-04 | 135 | 154 | 5 | EFO_0004870 | |
| Disease | Spinocerebellar Ataxia Type 2 | 7.41e-04 | 34 | 154 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 7.41e-04 | 34 | 154 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 7.41e-04 | 34 | 154 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 7.41e-04 | 34 | 154 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 7.41e-04 | 34 | 154 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 7.41e-04 | 34 | 154 | 3 | C0087012 | |
| Disease | bipolar II disorder | 7.42e-04 | 8 | 154 | 2 | EFO_0009964 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 7.42e-04 | 8 | 154 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | Alzheimer disease | 7.42e-04 | 8 | 154 | 2 | cv:C0002395 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | diastolic blood pressure, self reported educational attainment | 7.42e-04 | 8 | 154 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | breast ductal carcinoma (is_marker_for) | 7.42e-04 | 8 | 154 | 2 | DOID:3007 (is_marker_for) | |
| Disease | Schizophrenia | MAGI1 ACSL6 RAPGEF6 PSEN2 NFASC GRM1 GRM5 KMO PLA2G4B SLIT3 EDEM2 PLAT DNMT1 | 7.67e-04 | 883 | 154 | 13 | C0036341 |
| Disease | Spinocerebellar Ataxia Type 4 | 8.07e-04 | 35 | 154 | 3 | C0752122 | |
| Disease | aspartate aminotransferase measurement | MAGI1 RAPGEF6 THSD7A CACNA2D2 DNAH2 TNFRSF6B NSD1 SLCO1B3 NUBP1 PBX4 GLI1 EDEM2 LTBR | 9.50e-04 | 904 | 154 | 13 | EFO_0004736 |
| Disease | sex interaction measurement, Crohn's disease | 9.51e-04 | 37 | 154 | 3 | EFO_0000384, EFO_0008343 | |
| Disease | X-21467 measurement | 9.51e-04 | 9 | 154 | 2 | EFO_0020007 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0021020 | |
| Disease | leptin measurement, sex interaction measurement | 1.18e-03 | 10 | 154 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 1.44e-03 | 11 | 154 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | triacylglycerol 56:2 measurement | 1.44e-03 | 11 | 154 | 2 | EFO_0010429 | |
| Disease | extrapulmonary tuberculosis | 1.73e-03 | 12 | 154 | 2 | MONDO_0000368 | |
| Disease | Cardiomyopathy, Dilated | 2.03e-03 | 48 | 154 | 3 | C0007193 | |
| Disease | Respiratory Depression | 2.03e-03 | 13 | 154 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.03e-03 | 13 | 154 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.03e-03 | 13 | 154 | 2 | C1145670 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.03e-03 | 13 | 154 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.28e-03 | 50 | 154 | 3 | C1449563 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 154 | 8 | C3714756 | |
| Disease | response to calcium channel blocker | 3.16e-03 | 56 | 154 | 3 | EFO_0007767 | |
| Disease | Dementia | 3.50e-03 | 17 | 154 | 2 | C0497327 | |
| Disease | Bipolar Disorder | 3.69e-03 | 477 | 154 | 8 | C0005586 | |
| Disease | Hallux valgus | 3.84e-03 | 60 | 154 | 3 | HP_0001822 | |
| Disease | bipolar disorder, sex interaction measurement | 3.92e-03 | 18 | 154 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | age at menarche | 4.11e-03 | 594 | 154 | 9 | EFO_0004703 | |
| Disease | IGF-1 measurement | 4.23e-03 | 488 | 154 | 8 | EFO_0004627 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 4.37e-03 | 19 | 154 | 2 | EFO_0003100, GO_1902519 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPMEDGDKRCKLLLG | 11 | Q10589 | |
| LRCGMLIGPDKQAVA | 91 | Q6ZSB3 | |
| MRADPGVLAALCEKT | 531 | Q8WVB6 | |
| APMEDCVISILGRGL | 616 | P16452 | |
| GRDCTVEMPILKDLA | 41 | P56545 | |
| SDLPLMKVGICRNEG | 211 | A8MYA2 | |
| LDVLGRPMVLAGKEA | 466 | Q9NY47 | |
| FLTPCMRDLIKLAGV | 576 | P26358 | |
| RALEKALLDGMGSCL | 396 | Q13444 | |
| ALERPKGCMGVLARE | 41 | Q9NQ31 | |
| EGTKMGAVPCRRALL | 31 | Q8IY22 | |
| DLKGRMEAIPCVVGD | 56 | P30038 | |
| DGLCTRLIKPKVMEG | 161 | P41240 | |
| RKITIRELGGCMGPI | 76 | Q0P5N6 | |
| AEAFKRCVLLPLLGM | 166 | Q9ULJ7 | |
| RLRMHLGLVIPKEGC | 686 | Q12797 | |
| LMKLSGTIECEGPNR | 231 | Q9NTI2 | |
| LGLRPRGECHKVLEM | 1001 | Q07912 | |
| MALRELKVCLLGDTG | 1 | Q9UL26 | |
| LGLTEMPRGKFICNE | 1571 | Q96L73 | |
| VGDSRAILCRKGKPM | 206 | Q8N3J5 | |
| PGLAVMKTIDDLLRC | 11 | Q9NS91 | |
| MVFTPEDRLGKQCLL | 1 | Q9UN73 | |
| DIDICGPSIPKIMGL | 91 | P53384 | |
| AMGGGIVDLKECLER | 326 | P49441 | |
| QRVCSGEGLPKTDLM | 756 | Q9Y5H8 | |
| CDAMKPIDGRKLLES | 426 | P41594 | |
| GLPGSMKDTCKIVLA | 331 | Q6P0N0 | |
| LAEDGPAERCGKMRI | 1181 | Q96QZ7 | |
| PAERCGKMRIGDEIL | 1186 | Q96QZ7 | |
| DELMCIDGIPVKGKS | 771 | Q5TCQ9 | |
| RKCLLIVMECLDGGE | 131 | P49137 | |
| MEDCLLGGTRVSLPE | 26 | Q6P4R8 | |
| RDAPEKTLACMGLAI | 146 | Q9UJA3 | |
| ELILPIMVGCAKKGE | 241 | Q7Z5Y7 | |
| LVDDGTGRMPTLKKC | 526 | Q9HCQ5 | |
| PGLGKVKVMLRICST | 446 | Q2KJY2 | |
| MAQKPLRLLACGDVE | 1 | Q69YN2 | |
| CSGPLLRMAEEAARK | 146 | Q9BV94 | |
| DSKELRLIGMKLGCL | 411 | O95382 | |
| GLEGCEVMIPALKTI | 266 | Q9ULD0 | |
| GSGMLEILPKELELC | 1296 | Q9C000 | |
| TTLLKMADCGGLPQI | 281 | Q92597 | |
| LRELFKPSMAELGLC | 276 | O60447 | |
| LLKRLEACPGAVAMT | 471 | Q9H8E8 | |
| KLMNVLSLCGPESGL | 2361 | O94915 | |
| NLPMKEGCTEVSLLR | 301 | Q1KMD3 | |
| GIMTPGERIKCLLQI | 126 | O43772 | |
| SELDMLVGKCREEPL | 181 | P08151 | |
| LVGKCREEPLEGDMS | 186 | P08151 | |
| DLCGDLMEKRPVQVL | 246 | Q96MN2 | |
| MLILAGPEACGKREL | 416 | Q96M69 | |
| MKRLPESRICFLEGI | 486 | P0C869 | |
| LKAEALALLPCGLGM | 11 | O15442 | |
| CIFIAVLKMPSLEGR | 226 | Q8NGF4 | |
| VTCMRKVGKGSLDPE | 236 | Q15024 | |
| LGVKTIPDDTPMCRI | 1596 | Q6R327 | |
| NMTPALDKLEILRCG | 776 | Q96JM4 | |
| MGGCTVKPQLLLLAL | 1 | O00469 | |
| GDCPEMSIGAIKIAL | 116 | Q96RW7 | |
| KLECETRGLPMPAIT | 1566 | Q96RW7 | |
| KMPIDLVIEDRDGGC | 151 | A8K0S8 | |
| FDLLSRKMLGCPIND | 311 | Q96QZ0 | |
| SRLLVCDLGNPMKAG | 726 | P08648 | |
| LCLLSLGGAIEIPMD | 16 | O94856 | |
| NMLLAEGVCRPEKRG | 86 | Q9BYU1 | |
| GTFEKEMIGRIPCGR | 256 | Q16698 | |
| QGLLGMCPGERRKII | 216 | Q96AY3 | |
| CLGPEEMKRFALTLV | 841 | Q86XA9 | |
| RLEGLLCDVTLMPGD | 86 | Q9P2N7 | |
| LLKCNPEEGMITVLG | 136 | O15229 | |
| GKRICVGEGLARMEL | 431 | P33261 | |
| VSGVRLKPEMCDLLA | 406 | Q96Q40 | |
| VDCRKVAERPLGEMG | 986 | Q9P218 | |
| KDVLGRVGMTCPRLV | 321 | Q9UKT7 | |
| KDCRLTEPLGMRIAE | 471 | Q9H5Z1 | |
| MKEILGSPQRLCDLA | 366 | Q5TH69 | |
| VRVKEGKGMVLLCDP | 146 | Q12860 | |
| MEQLLALGKEARACP | 356 | Q92771 | |
| VGPMRGCRVKDLLDI | 651 | Q7Z388 | |
| LLEILGLLCKSMGPK | 1376 | Q04637 | |
| LLCMGPELVKIADFG | 131 | P20794 | |
| AVGPKLMRSDKLEVC | 166 | Q9NUK0 | |
| EMEVCKLPRLSLNGV | 756 | Q9P0L2 | |
| SPDGRIAVKACEGLM | 271 | Q5W0V3 | |
| VGLCDAMKPIDGSKL | 436 | Q13255 | |
| IGLIDLLSCMGLRPD | 561 | P49327 | |
| IFIDPCFGLKLELGM | 116 | Q9P225 | |
| GVVDIPAKMGALLLL | 386 | Q96S37 | |
| GGLACLIVMFLPEKK | 376 | Q8IZD6 | |
| PKEGRCLFVILLMAV | 36 | Q8WWT9 | |
| CGLPLGKGAAMIIET | 1016 | Q9UPQ0 | |
| AKTGVLGDIIMRPSC | 16 | Q9BYZ8 | |
| SVCKEEKMPRGGSLE | 411 | P51608 | |
| VMGEELCLVRFPDKL | 241 | Q9NSD7 | |
| LEKIPAMLGIDGLCA | 246 | Q6P4F7 | |
| CRGIPMVLIGCKTDL | 121 | Q9HBH0 | |
| PLCGLASMELGKEAI | 601 | Q2M3C7 | |
| GKRGCDCLVLEPSEM | 101 | Q8TEU7 | |
| ISKERALLPGDMGCR | 106 | Q8N8N0 | |
| LGEMKCTLVRGDSSP | 431 | A4FU49 | |
| FIAAIILCGDRPGLM | 351 | Q03181 | |
| VLCPKGPLRMLVETA | 261 | P49768 | |
| IKDIVTIGMLSLPCG | 271 | Q6UWJ1 | |
| PGELSCKRGDVLVML | 431 | Q5HYK7 | |
| DCILPEGKVEVLLGM | 971 | Q9UPZ6 | |
| SEMKLVCGFILEPRL | 701 | Q969F9 | |
| ERGGDITLRCPVMLV | 246 | Q9UN36 | |
| GRKDALAEPCFMLIG | 676 | Q9H3E2 | |
| MKGKCLLEVTGVADP | 961 | Q8IZX4 | |
| MGPGCDLLLRTAATI | 1 | P21675 | |
| MECLRGPALQVVSGL | 206 | Q9UL41 | |
| KIGALRMQLDPCEDT | 336 | Q92185 | |
| AKTLGTPLCPRMEDV | 506 | Q8TBZ3 | |
| MNIPALVGKGCLILS | 236 | Q9NUV7 | |
| LLKQPDLCGRREGMV | 611 | Q6IE81 | |
| EKPLLLHTGMGRLCT | 241 | Q9GZT8 | |
| LKECLVGRMAIKPAV | 121 | Q7L1T6 | |
| SLCGDLGLPLDMVEL | 441 | Q5JTZ9 | |
| LPCGMEKLGSDVATL | 776 | Q9NRP7 | |
| GDIRLLSDDMKALCP | 346 | Q9UKU0 | |
| LLCMGPELVKIADFG | 131 | Q9UPZ9 | |
| GLISKMLPGQDRGLC | 291 | Q15846 | |
| ARLLCAEMPKKAGAT | 21 | Q8WUR7 | |
| VKELLRCELCLGIMG | 321 | Q86TL0 | |
| DPRKALLIVGIPMEC | 16 | Q96PV4 | |
| VDCRGKGLMEIPANL | 291 | O75094 | |
| MRPLGCCMILIGIDE | 131 | P60900 | |
| GPMLVAEGETLLLRC | 46 | Q5JXA9 | |
| DGCVSDGKRKPVLMC | 266 | Q86UP3 | |
| PLVCLNDGRMTLVGI | 516 | P00750 | |
| VLDGGAICMELLTPR | 81 | A1L167 | |
| GISECLPRLTCMIRG | 311 | Q7Z3J2 | |
| LSCLEKRGLDMEGIL | 296 | Q5TG30 | |
| KIGEMPLTDSILCDG | 136 | Q9BWD1 | |
| LSPCIMITGKGVPDL | 241 | Q9Y5K1 | |
| ETPGLEGLKELMQLC | 251 | Q9Y572 | |
| LHRPKIIGAGCVIMG | 106 | Q9NYB5 | |
| LHRPKLIGIGCLLMG | 91 | Q9NPD5 | |
| GPGKCVLVLKEVLSM | 556 | Q5VUG0 | |
| MGLSLPKEKGLILCL | 41 | Q9H1D0 | |
| MRAAGLPELSCSKDI | 981 | O00329 | |
| MGERQPLKVFIDLCL | 141 | O60809 | |
| AVLCPKGPLRMLVET | 266 | P49810 | |
| KCPDTLQSREGLGRM | 696 | O95359 | |
| GLTIRDMLAGICEKR | 321 | O43566 | |
| DMLAGICEKRGLSLP | 326 | O43566 | |
| IKGEMSRPGEVCSAL | 121 | P07602 | |
| PVMGLEEIAPCTSKR | 106 | P36941 | |
| DLITCLEQGRKPLTM | 51 | Q68DY1 | |
| LLGKQVTLCLVEPMG | 1166 | Q7Z7G8 | |
| MGLLRGPLGEKDLDC | 141 | P17020 | |
| QELEEGCRPEGLLLM | 121 | O15482 | |
| RMEGCSGPVLLVLRD | 96 | A0PJX2 | |
| TKGRLIRSIMEECGG | 671 | Q00341 | |
| GCTLKLVLAMRGGPI | 91 | Q86XD8 | |
| ARCAGPQDMEGKLLL | 891 | O75093 | |
| CKIRDLLPVMCDRAG | 711 | Q93009 | |
| PLIERVKDCALMVEG | 631 | O95932 | |
| NIVPKLGMCLGELVI | 611 | Q9UBB9 | |
| MELKTACCIPGRREL | 271 | Q8NG06 | |
| ILGRPTTLCETMGKA | 246 | P0DTE5 | |
| MRALEGPGLSLLCLV | 1 | O95407 | |
| PGFKCMDLEDLGLSR | 241 | Q8IZF0 | |
| IEVMIAEPSCRGKGL | 106 | Q9BTE0 |